Adial Pharmaceuticals, Inc. - Common Stock (ADIL)

CUSIP: 00688A205

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock
Shares outstanding
5,493,768
Total 13F shares
264,302
Share change
+207,341
Total reported value
$491,452
Price per share
$1.86
Number of holders
14
Value change
+$385,501
Number of buys
8
Number of sells
1

Security key

00688A205

Report period

Q4 2023

Institutions

14

Top holders

10

Ownership snapshot

Top shareholders of ADIL - Adial Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Manchester Capital Manage...
13D/G signal
Evidence rows
10
Latest as of
30 Sep 2023
13F 3/4/5 Lead comparable stake: 0.88% Showing first 8 of 10 holder rows. Open remaining rows
Holder Evidence Ownership % Position 12M Net Δ As of
Manchester Capital Management LLC
13F
Company
13F
0.88%
$133,705
48,097 shares
30 Sep 2023
BlackRock Finance, Inc.
13F
Company
13F
0.14%
$21,236
7,639 shares
30 Sep 2023
OSAIC HOLDINGS, INC.
13F
Company
13F
0.01%
$1,710
615 shares
30 Sep 2023
UBS Group AG
13F
Company
13F
0.01%
$1,518
546 shares
30 Sep 2023
Abound Wealth Management
13F
Company
13F
0%
$76
27 shares
30 Sep 2023
MORGAN STANLEY
13F
Company
13F
0%
$58
21 shares
30 Sep 2023
WELLS FARGO & COMPANY/MN
13F
Company
13F
0%
$22
8 shares
30 Sep 2023
Qube Research & Technologies Ltd
13F
Company
13F
0%
$21
8 shares
30 Sep 2023
Show 2 additional holder rows in the full holder list
Holder Evidence Ownership % Position 12M Net Δ As of
William B. Stilley III
3/4/5
Director
mixed-class rows
$530,200
1,311,779 shares
mixed-class rows
23 May 2023
Dr. Bankole Johnson
3/4/5
Director
class O/S missing
40,000 shares
23 May 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
14
Shares
264,302
Rows loaded
14
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
8
Q4 2023 holders
14
Holder diff
6
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .